Mitsu Chem Plast Ltd Right Issue Shares 2024
- Published Date: February 26, 2024
- Updated Date: June 17, 2025
- By Team Choice
Mitsu Chem Plast Limited 2024 Right Issue Shares Detail
| Corporate Action | |
|---|---|
| Security Name | Mitsu Chem Plast Ltd |
| Issue Open/Close | February 26, 2024- March 4, 2024 |
| Record Date | February 17, 2024 |
| Issue Size (Amount) | ₹21.73 Crore |
| Issue Size (Shares) | ₹1,509,075 |
| Right Issue Price | ₹114 per share |
| Face Value | ₹10 Per Shares |
| CMP | ₹177 |
| Renunciation of Rights Entitlements | February 29, 2024 |
| Terms of Payment | Issue Price of Rs.144/- per Rights Equity Share. The amount of Rs.72/- per Rights Equity Share to be paid on Application. Balance to be paid on one call, as may be decided by Board |
| Entitlement | ₹1 Rights Equity Shares for every 8 fully paid-up Equity Shares held on Record Date |
Disclaimer: The Information compiled by CEBPL on a best efforts basis from information CEBPL received from third party vendors, believed to be reliable. The information may contain errors or omissions; and is subject to change without prior or additional notice. CEBPL provides corporate action information that may be of interest or relevance to CEBPL clients. This does not constitute a recommendation or advice by CEBPL, and CEBPL Clients may not rely upon it. CEBPL does not warrant that the information provided is accurate, timely, or complete. CEBPL Clients are urged to verify the information prior to using it in their investing and trading decisions, including, but not limited to, referral to independent financial news resources, company announcements, and regulatory filings or disclosures. "Investment in securities market are subject to market risks, read all the related documents carefully before investing". Registration granted by SEBI and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of retums to investors. Name of Compliance Officer-Prashant Salian Email Id-Prashant.salian@choiceindia.com Contact no. 022-67079999-Ext-2310. Name of Grievance Officer-Deepika Singhvi-Email Id-ig@choiceindia.com, Contact no. 022-67079999-Ext-834. www.choiceindia.com
Recommended for you
FII DII Data - Live Data
10 Best SIP Plans For ₹1000 Per Month in 2025
Pharma Mutual Funds – Best Option to Invest in 2025?
Invest in best pharma mutual funds in India for 2020 with Investica. Explore our top recommended pharma mutual funds to start investing today.
